Testicular tumours: BEP and spermatogenesis;Cancer du testicule: BEP et spermatogenèse

Andrologie

Volumn 12, Issue 3, 2002, Pages 277-283

  Daudin, Myriam ^a,b   Huyghe, Eric ^a   Chevreau, Christine ^b   Soulié, Michel ^c   Bujan, Louis ^a  

^a Centre de Sterilite Masculine   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

^c CHU RANGUEIL   (France)

Author keywords

BEP chemotherapy; Fertility; Sperm recovery; Spermatogenesis; Testicular cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ARTICLE; CANCER CHEMOTHERAPY; GERM CELL TUMOR; HUMAN; MALE; OLIGOSPERMIA; REPRODUCTIVE TOXICITY; SEMEN ANALYSIS; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS FUNCTION; TESTIS TUMOR;

EID: 0036760255     PISSN: 11662654     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03035140     Document Type: Article

References (37)

1. Adami H., Bergström R., Mohner M. et al.: Testicular cancer in nine Northern European countries. Int. J. Cancer, 1994, 59: 33-38.
2. Arai Y., Kawakita M., Okada Y. et al.: Sexuality and fertility in long-term survivors of testicular cancer. J. Clin. Oncol., 1997, 15, 4: 1444-1448.
3. Berthelsen J.G. and Skakkebaek N.E.: Gonadal function in men with testis cancer. Fertil. Steril., 1983, 39: 68-72.
4. Bohlen D., Burkhard F.C., Mills R. et al.: Fertility and sexual function following orchidectomy and 2 cycles of chemotherapy for stage I high risk non seminomatous germ cell cancer. J. Urol., 2001, 165: 441-444.
5. Bosl G.J., Motzer R.J.: Medical progress: Testicular germ-cell cancer. N. Engl. J. Med., 1997, 337: 242-253.
6. Brandriff B.F., Meistrich M.L., Gordon L.A. et al.: Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy. Hum. Genet., 1994, 93: 295-299.
7. Byrne J., Mulvihill J., Connelly R. et al.: Reproductive problems and birth defects in survivors of Wilms tumor and their relatives. Med. Pediatr. Oncol., 1988, 16: 233-240.
8. Chevreau C., Soulié M., Rischmann P.: Adjuvant chemotherapy in high risk stage I non seminomatous germ cell tumors. Proc. Am. Soc. Clin. Oncol., 1997, 16: 1149.
9. Costabile R.A.: The effects of cancer and cancer therapy on male reproductive function. J. Urol., 1993, 149: 1327-1330.
10. Cullen M.H., Stenning S.P., Parkinson M.C. et al.: Short-course adjuvant chemotherapy in high-risk stage I non seminomatous germ cell tumors of the testis: A Medical Research Council report. J. Clin. Oncol., 1996, 14,4: 1106-1113.
11. De Mas P., Daudin M., Vincent M.C. et al.: Increased aneuploidy in spermatozoa from testicular tumour patients after PEB chemotherapy. Hum. Reprod., 2001, 16: 1204-1208.
12. Einhorn L.H., Donohue J.: Cis-diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann. Intern. Med., 1997, 87: 293-298.
13. Forman D., Moller H.: Testicular cancer. Cancer Surg., 1994, 19/20: 324-341.
14. Fossa S.D., Aass N., Kaalhus O.: Testicular cancer in young Norwegians. J. Surg. Oncol., 1988, 39: 43-63.
15. Genesca A., Caballin M.R., Miro R. et al.: Human sperm chromosomes: Long-term effect of cancer treatment. Cancer Genet. Cytogenet., 1990, 46: 251-260.
16. Genesca A., Miro R., Caballin M.R. et al.: Sperm chromosome studies in individuals treated for testicular cancer. Hum. Reprod., 1990, 5, 3: 286-290.
17. Guazzieri S., Lembo A., Ferro G. et al.: Sperm antibodies and infertility in patients with testicular cancer. Urology, 1985, 26: 139-142.
18. Holmes G.F. and Holmes F.F.: Pregnancy outcome of patients treated for Hodgkin's disease. Cancer, 1978, 41: 13-17.
19. Li F.P., Fine W., Jaffe N. et al.: Offspring of patients treated for cancer in childhood. J. Nat. Cancer Inst., 1979, 62: 1193-1198.
20. Martin R.H., Hildebrand K., Yamamoto J. et al.: An increased frequency of human sperm chromosomal abnormalities after radiotherapy. Mutat. Res., 1986, 174: 219-225.
21. Martin R., Ernst S., Rademaker A. et al.: Chromosomal abnormalities in sperm from testicular cancer patients before and after chemotherapy. Hum. Genet., 1997, 99: 214-218.
22. Martin R.H., Ernst S., Rademaker A. et al.: Analysis of sperm chromosome complements before, during, and after chemotherapy. Cancer Genet. Cytogenet., 1999, 108: 133-136.
23. Meistrich M.L.: Potential genetic risk of using semen collected during chemotherapy. Hum. Reprod., 1993, 8,: 8-10.
24. Meirow D., Schenker J.G.: Cancer and male infertility. Hum. Reprod., 1995, 10: 2017-2022.
25. Mieusset R., Bujan L., Mondinat C., et al.: Association of scrotal hyperthermia with impaired spermatogenesis in infertile men. Fertil. Steril., 1987, 48: 1006-1011.
26. Oliver R.T.D., Raja M.A., Ong J. et al.: Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage I malignant teratoma on overall relapse rate of stage I cancer patients. J. Urol., 1992, 148: 1453-1456.
27. Petersen P.M., Hansen S.W., Giwercman A. et al.: Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann. Oncol., 1994, 5: 355-358.
28. Petersen P.M., Skakkebaek N.E., Rorth M. et al.: Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer. J. Urol., 1999, 161: 822-826.
29. Pont J., Albrecht W., Postner G. et al.: Adjuvant chemotherapy for high-risk clinical stage I non seminomatous testicular germ cell cancer: Long-term results of a prospective trial. J. Clin. Oncol., 1996, 14, 2: 441-448.
30. Pont J., Albrecht W.: Fertility after chemotherapy for testicular germ cell cancer. Fertil. Steril., 1997, 68, 1: 1-5.
31. Richie J.P.: Detection and treatment of testicular cancer. CA Cancer J. Clin., 1993, 43: 151-175.
32. Smithers D.W., Wallace D.M., Austin D.E.: Fertility after unilateral orchidectomy and radiotherapy for patients with malignant tumours of the testis. Br. Med. J., 1973, 2: 77-79.
33. Studer U.E., Fey M.F., Calderoni A. et al.: Adjuvant chemotherapy after orchidectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. Eur. Urol., 1993, 23: 444-449.
34. Sturgeon J.F.G., Jewett M.A.S., Alison R.E. et al.: Surveillance after orchidectomy for patients with clinical stage I non seminomatous testis tumours. J. Clin. Oncol., 1992, 10: 564-568.
35. Thompson P.I., Nixon J. and Harvey V.J.: Disease relapse in patients with stage I non-seminomatous germ cell tumour of the testis on active surveillance. J. Clin. Oncol., 1988, 6: 1597-1603.
36. Van Basten J.P., Jonker-Pool G., Van Driel M.F. et al.: The sexual sequelae of testicular cancer. Cancer Treat. Rev., 1995, 21: 479-495.
37. Williams S.D., Birch R., Einhorn L.H. et al.: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N. Engl. J. Med., 1987, 316: 1435-1440.